Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04950725 · ClinicalTrials.gov registry record · NA

Covid-19 Virtual Recovery Study

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
2,268
Enrollment target

NCT04950725: Completed NA study, sponsored by Mayo Clinic.

NCT04950725 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 2,268 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04950725, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
2,268 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effects of respiratory muscle training (RMT) and nasal breathing on patients who have been infected with the SARS-CoV2 virus and continue to have lingering symptoms.

Interventions

  • BEHAVIORAL Strength RMT
  • BEHAVIORAL Strength RMT and nasal breathing
  • BEHAVIORAL Endurance RMT
  • BEHAVIORAL Endurance RMT and nasal breathing
  • BEHAVIORAL Low dose RMT

Trial Details

FieldValue
Enrollment Target 2,268 participants
Start Date 2021-11-01
Est. Completion 2023-07-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04950725

The ClinicalTrials.gov registry entry for NCT04950725 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,268 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Strength RMT is the first listed.

NCT04950725 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04950725 about?

NCT04950725 is a clinical study titled "Covid-19 Virtual Recovery Study". The purpose of this study is to determine the effects of respiratory muscle training (RMT) and nasal breathing on patients who have been infected with the SARS-CoV2 virus and continue to have lingering symptoms.

What is the current status of trial NCT04950725?

This trial is currently completed. It is a NA study. The enrollment target is 2,268 participants. The study started on 2021-11-01. Estimated completion is 2023-07-01.

What interventions are being tested in trial NCT04950725?

The interventions under investigation include: Strength RMT (BEHAVIORAL), Strength RMT and nasal breathing (BEHAVIORAL), Endurance RMT (BEHAVIORAL), Endurance RMT and nasal breathing (BEHAVIORAL), Low dose RMT (BEHAVIORAL).

Who is sponsoring clinical trial NCT04950725?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.